Bacteria blocks Zika transmission in Aedes, study finds
Researchers from the University of Wisconsin-Madison report that a harmless bacterium called Wolbachia pipientis prevents transmission of the Zika virus by the Aedes aegypti mosquito. The research was published today in the journal Scientific Reports and offers hope that Wolbachia could be a cost-effective weapon against Zika.
The research team introduced Wolbachia into Aedes mosquitoes in Medellin, Colombia. In the study, female mosquitoes housing Wolbachia fed on Zika-infected mice or membranes containing Zika-infected sheep's blood. They had low to undeductible levels of Zika virus compared with the controls and were incapable of transmission. In comparison, 95% of the control mosquitoes were capable of spreading the virus 7 days after feeding.
Wolbachia has previously been investigated as a tool to control dengue virus transmission, and other studes have shown it to be effective against Zika, as well. The bacterium is often found in butterflies and bees but not mosquitoes. Researchers are optimistic the bacteria could provide a low-cost way to control the spread of Aedes-transmitted illnesses, including chikungunya, yellow fever, and dengue.
Currently, the Bill and Melinda Gates Foundation is funding pilot testing and introduction of Wolbachia to mosquito populations in Australia, Brazil, Colombia, Indonesia, and Vietnam. Researchers hope that once the bacterium infects 80% of mosquitoes in a region, the rate of Zika transmission will be greatly reduced. Once a female mosquito is infected with Wolbachia, she passes the infection to her offspring.
It's estimated that the Zika virus could infect 4 million people this year, causing illnesses ranging from mild, transient fever to microcephaly and Guillain-Barre syndrome.
Jul 1 Sci Rep study
May 5 CIDRAP News story "Bacteria shown to curb mosquitoes' ability to spread Zika"
CIDRAP Zika resource page
Whole-blood testing may provide wider window for Zika diagnosis
Whole blood isolated from five patients with Zika tested positive for the virus for up to 58 days following symptom onset, a much longer diagnostic window than that provided by urine or serum samples, according to a study yesterday in Eurosurveillance.
A research team led by Israel's Ministry of Health analyzed whole-blood, serum, and urine specimens from six travelers to Zika-endemic areas diagnosed with the illness between December 2015 and April 2016. The patients ranged in age from 3 to 61 years, and two were male, the authors said.
Among six whole-blood samples obtained from five patients who tested positive for Zika RNA by real-time polymerase chain reaction), one remained positive for 58 days following symptom onset. In contrast, among urine specimens, the longest duration of positive results was 26 days in one of the three positive samples, and among five positive serum samples the longest was only 3 days. The authors also found a substantially higher quantity of Zika virus RNA in whole blood (88 plaque-forming units, or PFUs) in comparison with the 16 PFUs in urine samples.
The authors said that all samples of whole blood were positive for viral RNA during the first month following illness onset, three were positive during the second month, and all were negative after 2 months.
Whole blood may provide a more accurate and larger diagnostic window for Zika virus, an improvement in detection capability that may help in addressing the illness during pregnancy and in preventing sexual transmission, the authors said.
Jun 30 Eurosurveillance study
Feds award $25 million to local health departments for Zika preparation
Funding in the amount of $25 million to support Zika virus protection has been provided by the federal government to 53 state, city, and territorial health departments in the United States, says an announcement from the Centers for Disease Control and Prevention (CDC) today.
The recipients are areas of the country deemed at risk for local Zika transmission as determined by the estimated range of the Aedes mosquito species known to transmit the virus, a history of mosquito-borne disease outbreaks, and population, says the CDC press release.
The funds are available as of today and can be used through June of next year to identify and investigate possible outbreaks, coordinate comprehensive responses across all levels of government and nongovernmental partners, identify and connect families affected by Zika to community services, and buy preparedness resources like repellent, screens, and supplies for prevention kits.
The announcement also says that the CDC "has awarded $567.5 million in cooperative agreements to 62 public health departments across the country to improve and sustain emergency preparedness of state and local public health systems." These monies come from Public Health Emergency Preparedness (PHEP) cooperative agreement funds, which annually provide resources for local communities to plan for and respond to various emergency events.
The Obama administration has asked for $1.9 billion in federal Zika funding, but action on the request has so far been held up by various congressional controversies.
Jul 1 CDC press release